Literature DB >> 21830992

The genetic blueprint of major depressive disorder: contributions of imaging genetics studies.

Christian Scharinger1, Ulrich Rabl, Lukas Pezawas, Siegfried Kasper.   

Abstract

OBJECTIVES: To review neuroimaging intermediate phenotypes of MDD and their relation to genetic risk variants.
METHODS: A systematic literature search of peer-reviewed English language articels using PubMed ( www.pubmed.org ) was performed.
RESULTS: Comprehensive evidence on the influence of serotonergic genes (SLC6A4, HTR1A, MAOA, TPH2) and BDNF on the following neural intermediate phenotypes is displayed: amygdala reactivity, coupling of amygdala-anterior cingulate cortex (ACC) activity, ACC volume, hippocampal volume and serotonin receptor 1A (5-HT1A) binding potential (BP).
CONCLUSIONS: Intermediate phenotypes may bridge the gap between genotype and phenotype by reducing the impreciseness of psychiatric phenotypes and yield more insights into the underlying biology.

Entities:  

Mesh:

Year:  2011        PMID: 21830992     DOI: 10.3109/15622975.2011.596220

Source DB:  PubMed          Journal:  World J Biol Psychiatry        ISSN: 1562-2975            Impact factor:   4.132


  12 in total

Review 1.  From psychiatric disorders to animal models: a bidirectional and dimensional approach.

Authors:  Zoe R Donaldson; René Hen
Journal:  Biol Psychiatry       Date:  2014-02-17       Impact factor: 13.382

Review 2.  Neuroimaging genomic studies in major depressive disorder: A systematic review.

Authors:  Hui-Feng Zhang; David Mellor; Dai-Hui Peng
Journal:  CNS Neurosci Ther       Date:  2018-02-23       Impact factor: 5.243

3.  microRNAs as Biomarker in Depression Pathogenesis.

Authors:  Yogesh Dwivedi
Journal:  Ann Psychiatry Ment Health       Date:  2013-12-02

4.  [Serotonin transporter gene and stress reactivity in unipolar depression. Role of the HPA system as endophenotype of the SLC6A4 gene].

Authors:  H Welper; A Aller; V Guttenthaler; S Höfels; L Lennertz; U Pfeiffer; S G Schwab; A Zobel
Journal:  Nervenarzt       Date:  2014-03       Impact factor: 1.214

Review 5.  The genetics of anxiety-related negative valence system traits.

Authors:  Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-19       Impact factor: 3.568

6.  No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Authors:  Richard Musil; Peter Zill; Florian Seemüller; Brigitta Bondy; Michael Obermeier; Ilja Spellmann; Wolfram Bender; Mazda Adli; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Wolfgang Maier; Marcella Rietschel; Dan Rujescu; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-11       Impact factor: 5.270

7.  Epigenetic Modulation of Mood Disorders.

Authors:  T Archer; M Oscar-Berman; K Blum; Ms Gold
Journal:  J Genet Syndr Gene Ther       Date:  2013-02-11

8.  Imaging-genetics in autism spectrum disorder: advances, translational impact, and future directions.

Authors:  Stephanie H Ameis; Peter Szatmari
Journal:  Front Psychiatry       Date:  2012-05-15       Impact factor: 4.157

9.  Modulatory effects of the piccolo genotype on emotional memory in health and depression.

Authors:  Saskia Woudstra; Marie-José van Tol; Zoltán Bochdanovits; Nic J van der Wee; Frans G Zitman; Mark A van Buchem; Esther M Opmeer; André Aleman; Brenda W Penninx; Dick J Veltman; Witte J Hoogendijk
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

10.  fMRI measurements of amygdala activation are confounded by stimulus correlated signal fluctuation in nearby veins draining distant brain regions.

Authors:  Roland N Boubela; Klaudius Kalcher; Wolfgang Huf; Eva-Maria Seidel; Birgit Derntl; Lukas Pezawas; Christian Našel; Ewald Moser
Journal:  Sci Rep       Date:  2015-05-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.